TVTX logo

Travere Therapeutics, Inc. (TVTX) Free Cash Flow

Annual FCF:

-$273.69M+$48.59M(+15.08%)
December 31, 2024

Summary

  • As of today, TVTX annual free cash flow is -$273.69 million, with the most recent change of +$48.59 million (+15.08%) on December 31, 2024.
  • During the last 3 years, TVTX annual free cash flow has fallen by -$234.74 million (-602.79%).

Performance

TVTX Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXcash flow metrics

Quarterly FCF:

-$7.34M+$46.64M(+86.41%)
June 30, 2025

Summary

  • As of today, TVTX quarterly free cash flow is -$7.34 million, with the most recent change of +$46.64 million (+86.41%) on June 30, 2025.
  • Over the past year, TVTX quarterly free cash flow has increased by +$44.90 million (+85.95%).
  • TVTX quarterly free cash flow is now -127.49% below its all-time high of $26.69 million, reached on September 30, 2021.

Performance

TVTX Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXcash flow metrics

TTM FCF:

-$157.30M+$44.90M(+22.21%)
June 30, 2025

Summary

  • As of today, TVTX TTM free cash flow is -$157.30 million, with the most recent change of +$44.90 million (+22.21%) on June 30, 2025.
  • Over the past year, TVTX TTM free cash flow has increased by +$160.47 million (+50.50%).

Performance

TVTX TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

TVTX Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+15.1%+86.0%+50.5%
3Y3 Years-602.8%+84.8%-37.7%
5Y5 Years-271.0%+32.6%-195.1%

TVTX Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-602.8%+15.1%at high+94.2%at high+53.5%
5Y5-Year-602.8%+15.1%-127.5%+94.2%-436.2%+53.5%
All-TimeAll-Time>-9999.0%+15.1%-127.5%+94.2%>-9999.0%+53.5%

TVTX Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$7.34M(+86.4%)
-$157.30M(+22.2%)
Mar 2025
-
-$53.98M(-19.2%)
-$202.19M(+26.1%)
Dec 2024
-$273.69M(+15.1%)
-$45.28M(+10.7%)
-$273.69M(+10.1%)
Sep 2024
-
-$50.70M(+2.9%)
-$304.41M(+4.2%)
Jun 2024
-
-$52.24M(+58.4%)
-$317.77M(+6.2%)
Mar 2024
-
-$125.47M(-65.1%)
-$338.67M(-5.1%)
Dec 2023
-$322.28M(-50.0%)
-$76.00M(-18.6%)
-$322.28M(-5.6%)
Sep 2023
-
-$64.06M(+12.4%)
-$305.11M(-5.9%)
Jun 2023
-
-$73.13M(+33.0%)
-$288.21M(-9.4%)
Mar 2023
-
-$109.08M(-85.4%)
-$263.35M(-22.6%)
Dec 2022
-$214.85M(-451.7%)
-$58.84M(-24.8%)
-$214.85M(-14.2%)
Sep 2022
-
-$47.16M(+2.3%)
-$188.09M(-64.6%)
Jun 2022
-
-$48.27M(+20.3%)
-$114.24M(-79.1%)
Mar 2022
-
-$60.59M(-88.9%)
-$63.79M(-63.8%)
Dec 2021
-$38.94M(+42.1%)
-$32.08M(-220.2%)
-$38.94M(-32.7%)
Sep 2021
-
$26.69M(+1119.2%)
-$29.34M(+47.8%)
Jun 2021
-
$2.19M(+106.1%)
-$56.21M(+18.9%)
Mar 2021
-
-$35.74M(-59.1%)
-$69.28M(-2.9%)
Dec 2020
-$67.31M(+8.8%)
-$22.47M(>-9900.0%)
-$67.31M(-26.3%)
Sep 2020
-
-$180.00K(+98.3%)
-$53.31M(+25.4%)
Jun 2020
-
-$10.89M(+67.8%)
-$71.47M(+14.0%)
Mar 2020
-
-$33.77M(-298.6%)
-$83.08M(-12.6%)
Dec 2019
-$73.78M(-65.2%)
-$8.47M(+53.8%)
-$73.78M(-1.4%)
Sep 2019
-
-$18.34M(+18.5%)
-$72.74M(-17.0%)
Jun 2019
-
-$22.50M(+8.1%)
-$62.14M(-34.7%)
Mar 2019
-
-$24.47M(-229.3%)
-$46.14M(-3.3%)
Dec 2018
-$44.66M(-576.0%)
-$7.43M(+4.0%)
-$44.66M(-8.9%)
Sep 2018
-
-$7.74M(-19.2%)
-$41.02M(-33.1%)
Jun 2018
-
-$6.49M(+71.8%)
-$30.82M(-36.9%)
Mar 2018
-
-$22.99M(-506.0%)
-$22.50M(-240.7%)
Dec 2017
-$6.61M
-$3.79M(-254.0%)
-$6.61M(+52.2%)
Sep 2017
-
$2.46M(+35.6%)
-$13.81M(+3.5%)
Jun 2017
-
$1.82M(+125.6%)
-$14.31M(+0.9%)
DateAnnualQuarterlyTTM
Mar 2017
-
-$7.09M(+35.5%)
-$14.45M(-6.8%)
Dec 2016
-$13.52M(-78.3%)
-$10.99M(-662.1%)
-$13.52M(-98.9%)
Sep 2016
-
$1.96M(+16.2%)
-$6.80M(+39.3%)
Jun 2016
-
$1.68M(+127.3%)
-$11.21M(-75.3%)
Mar 2016
-
-$6.17M(-44.3%)
-$6.39M(+15.7%)
Dec 2015
-$7.58M(+84.8%)
-$4.27M(-74.3%)
-$7.58M(+39.3%)
Sep 2015
-
-$2.45M(-137.7%)
-$12.49M(+51.4%)
Jun 2015
-
$6.50M(+188.3%)
-$25.69M(+45.5%)
Mar 2015
-
-$7.36M(+19.8%)
-$47.14M(+5.4%)
Dec 2014
-$49.81M(-115.3%)
-$9.18M(+41.4%)
-$49.81M(+6.0%)
Sep 2014
-
-$15.66M(-4.8%)
-$53.01M(-32.5%)
Jun 2014
-
-$14.95M(-49.0%)
-$40.02M(-46.7%)
Mar 2014
-
-$10.03M(+18.9%)
-$27.29M(-17.9%)
Dec 2013
-$23.14M(-488.8%)
-$12.37M(-363.6%)
-$23.14M(-114.8%)
Sep 2013
-
-$2.67M(-20.3%)
-$10.77M(-32.9%)
Jun 2013
-
-$2.22M(+62.3%)
-$8.10M(-37.7%)
Mar 2013
-
-$5.89M(>-9900.0%)
-$5.89M(>-9900.0%)
Dec 2012
-$3.93M(>-9900.0%)
-
-
Nov 2011
-
$0.00(0.0%)
-$600.00(+14.3%)
Aug 2011
-
$0.00(0.0%)
-$700.00(0.0%)
May 2011
-
$0.00(+100.0%)
-$700.00(0.0%)
Feb 2011
-$700.00(-600.0%)
-$600.00(-500.0%)
-$700.00(-600.0%)
Nov 2010
-
-$100.00(>-9900.0%)
-$100.00(>-9900.0%)
Aug 2010
-
$0.00(0.0%)
$0.00(+100.0%)
May 2010
-
$0.00(0.0%)
-$100.00(0.0%)
Feb 2010
-$100.00(+99.5%)
$0.00(0.0%)
-$100.00(0.0%)
Nov 2009
-
$0.00(+100.0%)
-$100.00(+66.7%)
Aug 2009
-
-$100.00(>-9900.0%)
-$300.00(-50.0%)
May 2009
-
$0.00(0.0%)
-$200.00(+99.0%)
Feb 2009
-$20.20K(>-9900.0%)
$0.00(+100.0%)
-$20.20K(0.0%)
Nov 2008
-
-$200.00(>-9900.0%)
-$20.20K(-1.0%)
Aug 2008
-
$0.00(+100.0%)
-$20.00K(0.0%)
May 2008
-
-$20.00K
-$20.00K
Feb 2008
$0.00
-
-

FAQ

  • What is Travere Therapeutics, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. annual free cash flow year-on-year change?
  • What is Travere Therapeutics, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. quarterly free cash flow year-on-year change?
  • What is Travere Therapeutics, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. TTM free cash flow year-on-year change?

What is Travere Therapeutics, Inc. annual free cash flow?

The current annual free cash flow of TVTX is -$273.69M

What is the all-time high annual free cash flow for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high annual free cash flow is $0.00

What is Travere Therapeutics, Inc. annual free cash flow year-on-year change?

Over the past year, TVTX annual free cash flow has changed by +$48.59M (+15.08%)

What is Travere Therapeutics, Inc. quarterly free cash flow?

The current quarterly free cash flow of TVTX is -$7.34M

What is the all-time high quarterly free cash flow for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high quarterly free cash flow is $26.69M

What is Travere Therapeutics, Inc. quarterly free cash flow year-on-year change?

Over the past year, TVTX quarterly free cash flow has changed by +$44.90M (+85.95%)

What is Travere Therapeutics, Inc. TTM free cash flow?

The current TTM free cash flow of TVTX is -$157.30M

What is the all-time high TTM free cash flow for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high TTM free cash flow is $0.00

What is Travere Therapeutics, Inc. TTM free cash flow year-on-year change?

Over the past year, TVTX TTM free cash flow has changed by +$160.47M (+50.50%)
On this page